Nektar announces clinical trial agreement to evaluate rezpegaldesleukin in patients with new onset type 1 diabetes mellitus: San Francisco Tuesday, February 25, 2025, 18:00 Hrs [I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback